Yifan Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yifan Zhong has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Chang Chen
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China
2 shared publications - Dong Xie
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications Jiajun Deng
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsMengmeng Zhao
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsBentong Yu
Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Jiangxi, China
1 shared publicationChunyan Wu
Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 29 January 2025
- Published by Springer Nature in npj Digital Medicine
- Vol. 8 (1) , 1-12
Whole slide image based deep learning refines prognosis and therapeutic response evaluation in lung adenocarcinoma
Existing prognostic models are useful for estimating the prognosis of lung adenocarcinoma patients, but there remains room for improvement. In the current study, we developed a deep learning model based on histopathological images to predict the recurrence risk of lung adenocarcinoma patients. The efficiency of the model was then evaluated in independent multicenter cohorts. The model defined high- and low-risk groups successfully stratified prognosis of the entire cohort. Moreover, multivariable Cox analysis identified the model defined risk groups as an independent predictor for disease-free survival. Importantly, combining TNM stage with the established model helped to distinguish subgroups of patients with high-risk stage II and stage III disease who are highly likely to benefit from adjuvant chemotherapy. Overall, our study highlights the significant value of the constructed model to serve as a complementary biomarker for survival stratification and adjuvant therapy selection for lung adenocarcinoma patients after resection.
- 29 January 2025
- Published by Springer Nature in npj Digital Medicine
- Vol. 8 (1) , 1-12
Open AccessWhole slide image based deep learning refines prognosis and therapeutic response evaluation in lung adenocarcinoma
Existing prognostic models are useful for estimating the prognosis of lung adenocarcinoma patients, but there remains room for improvement. In the current study, we developed a deep learning model based on histopathological images to predict the recurrence risk of lung adenocarcinoma patients. The efficiency of the model was then evaluated in independent multicenter cohorts. The model defined high- and low-risk groups successfully stratified prognosis of the entire cohort. Moreover, multivariable Cox analysis identified the model defined risk groups as an independent predictor for disease-free survival. Importantly, combining TNM stage with the established model helped to distinguish subgroups of patients with high-risk stage II and stage III disease who are highly likely to benefit from adjuvant chemotherapy. Overall, our study highlights the significant value of the constructed model to serve as a complementary biomarker for survival stratification and adjuvant therapy selection for lung adenocarcinoma patients after resection.
- 1 November 2021
- Published by Elsevier in Cancer Letters
- Vol. 520, 321-331
A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis
- 1 November 2021
- Published by Elsevier in Cancer Letters
- Vol. 520, 321-331
A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis
- Open Access
- 1 November 2020
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (21) , 1352
Development and validation of a risk perception scale of medical help-seeking behavior in Chinese adults
Background: When people require medical treatment, many risk factors including adverse medical events, economic burdens, and social–psychological consequences may contribute to their hesitation to seek medical help. Therefore, a reliable and valid instrument that can comprehensively assess the risk perception of medical help-seeking behavior among ordinary Chinese adults should be developed. Methods: The basic dimensions of the scale were determined based on literature review and in-depth interviews with patients. Then, an item pool with 32 items and six dimensions was developed. After the item reduction process based on item and factor analyses, a three-factor, 16-item scale was established. From March 2019, this scale was distributed among 639 healthy adults, outpatients, or inpatients in 20 provinces and municipalities in the mainland of China by convenience sampling. Then, the reliability and validity of the scale were examined. Results: The scale consists of three dimensions (treatment risks, burden risks, and stigma risks) and 16 items. The root-mean-square error of approximation, comparative fit index, and Tucker-Lewis index of this model were 0.069, 0.925, and 0.910, respectively. The internal consistency reliability of the scale was 0.893, and the test-retest reliability was 0.784. The criterion-related validity was 0.720 (PConclusions: The risk perception scale of medical help-seeking behavior is a reliable and valid instrument to measure Chinese adults’ perception for potential risks in the process of medical treatment.
- 1 November 2020
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (21) , 1352
Open AccessDevelopment and validation of a risk perception scale of medical help-seeking behavior in Chinese adults
Background: When people require medical treatment, many risk factors including adverse medical events, economic burdens, and social–psychological consequences may contribute to their hesitation to seek medical help. Therefore, a reliable and valid instrument that can comprehensively assess the risk perception of medical help-seeking behavior among ordinary Chinese adults should be developed. Methods: The basic dimensions of the scale were determined based on literature review and in-depth interviews with patients. Then, an item pool with 32 items and six dimensions was developed. After the item reduction process based on item and factor analyses, a three-factor, 16-item scale was established. From March 2019, this scale was distributed among 639 healthy adults, outpatients, or inpatients in 20 provinces and municipalities in the mainland of China by convenience sampling. Then, the reliability and validity of the scale were examined. Results: The scale consists of three dimensions (treatment risks, burden risks, and stigma risks) and 16 items. The root-mean-square error of approximation, comparative fit index, and Tucker-Lewis index of this model were 0.069, 0.925, and 0.910, respectively. The internal consistency reliability of the scale was 0.893, and the test-retest reliability was 0.784. The criterion-related validity was 0.720 (PConclusions: The risk perception scale of medical help-seeking behavior is a reliable and valid instrument to measure Chinese adults’ perception for potential risks in the process of medical treatment.